The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 3, 2006, Pages

  Everett Grueter, Carrie ^a,b   Edgerton, Dale S ^a   Donahue, E Patrick ^a   Vaughan, Suzan ^a   Chang, An Chu ^a,d   Sindelar, Dana K ^a,c   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d Hurley Consulting Associates   (United States)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Canine; Gluconeogenesis; Glycogenolysis; Nonesterified fatty acids

Indexed keywords

ACETOACETIC ACID; FATTY ACID; GLUCAGON; GLUCOSE; HEPARIN; INSULIN; INTRALIPID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FAT INTAKE; FATTY ACID METABOLISM; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HORMONE ACTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIVER BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; CYCLIC AMP; DOGS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCEROL; GLYCOGENOLYSIS; HEPARIN; HYPERGLYCEMIA; INSULIN; LACTIC ACID; LIVER;

EID: 33748475021     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00043.2006     Document Type: Article

References (66)

1. Ally A and Park G. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. J Chromatogr 575: 19-27, 1992.
2. Boden G, Chen X, Capulong E, and Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001.
3. Bonadonna RC and De Fronzo RA. Glucose metabolism in obesity and type 2 diabetes. Diabete Metab 17: 112-135, 1991.
4. Bouscarel B, Gettys TW, Fromm H, and Dubner H. Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am J Physiol Gastrointest Liver Physiol 268: G300-G310, 1995.
5. Chalkley SM, Hettiarachchi M, Chisholm DJ, and Kraegen EW. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: 1121-1126, 1998.
6. Chen X, Iqbal N, and Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
7. Cherrington AD, Fuchs H, Stevenson RW, Williams PE, Alberti KG, and Steiner KE. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol Endocrinol Metab 247: E137-E144, 1984.
8. Cherrington AD, Williams PE, Shulman GI, and Lacy WW. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30: 180-187, 1981.
9. Chhibber VL, Soriano C, and Tayek JA. Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. Metabolism 49: 39-46, 2000.
10. Chu CA, Galassetti P, Igawa K, Sindelar DK, Neal DW, Burish M, and Cherrington AD. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs. Am J Physiol Endocrinol Metab 284: E291-E301, 2003.
11. Chu CA, Sherck SM, Igawa K, Sindelar DK, Neal DW, Emshwiller M, and Cherrington AD. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am J Physiol Endocrinol Metab 282: E402-E411, 2002.
12. 2-receptors in the dog. Am J Physiol Endocrinol Metab 279: E463-E473, 2000.
13. Chu CA, Sindelar DK, Neal DW, Allen EJ, Donahue EP, and Cherrington AD. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 99: 1044-1056, 1997.
14. Chu CA, Sindelar DK, Neal DW, and Cherrington AD. Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis. Am J Physiol Endocrinol Metab 271: E127-E137, 1996.
15. Clore JN, Glickman PS, Nestler JE, and Blackard WG. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol Endocrinol Metab 261: E425-E429, 1991.
16. Clore JN, Stillman JS, Li J, O'Keefe SJ, and Levy JR. Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab 287: E358-E365, 2004.
17. Connolly CC, Stevenson RW, Neal DW, Wasserman DH, and Cherrington AD. The effects of lactate loading on alanine and glucose metabolism in the conscious dog. Metabolism 42: 154-161, 1993.
18. Davis MA, Williams PE, and Cherrington AD. Effect of glucagon on hepatic lactate metabolism in the conscious dog. Am J Physiol Endocrinol Metab 248: E463-E470, 1985.
19. Diamond MP, Rollings RC, Steiner KE, Williams PE, Lacy WW, and Cherrington AD. Effect of alanine concentration independent of changes in insulin and glucagon on alanine and glucose homeostasis in the conscious dog. Metabolism 37: 28-33, 1988.
20. Dinneen S, Alzaid A, Turk D, and Rizza R. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38: 337-343, 1995.
21. Dobbins RL, Davis SN, Neal DW, Cobelli C, and Cherrington AD. Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog. Am J Physiol Endocrinol Metab 266: E467-E478, 1994.
22. Edgerton DS, Cardin S, Neal D, Farmer B, Lautz M, Pan C, and Cherrington AD. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog. Am J Physiol Endocrinol Metab 286: E510-E522, 2004.
23. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 3: 163-183, 1987.
24. Friedmann B, Goodman EH Jr, and Weinhouse S. Effects of insulin and fatty acids on gluconeogenesis in the rat. J Biol Chem 242: 3620-3627, 1967.
25. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, and Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
26. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Donahue EP, Flakoll P, and Cherrington AD. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am J Physiol Endocrinol Metab 284: E695-E707, 2003.
27. Gustavson SM, Chu CA, Nishizawa M, Farmer B, Neal D, Yang Y, Vaughan S, Donahue EP, Flakoll P, and Cherrington AD. Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion. Am J Physiol Endocrinol Metab 285: E534-E544, 2003.
28. Hamilton KS, Gibbons FK, Bracy DP, Lacy DB, Cherrington AD, and Wasserman DH. Effect of prior exercise on the partitioning of an intestinal glucose load between splanchnic bed and skeletal muscle. J Clin Invest 98: 125-135, 1996.
29. Hernandez-Sotomayor SM, Macias-Silva M, Malbon CC, and Garcia-Sainz JA. Modulation of Gs activity by phorbol myristate acetate in rat hepatocytes. Am J Physiol Cell Physiol 260: C259-C265, 1991.
30. Hornbuckle LA, Everett CA, Martin CC, Gustavson SS, Svitek CA, Oeser JK, Neal DW, Cherrington AD, and O'Brien RM. Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ. Am J Physiol Endocrinol Metab 286: E795-E808, 2004.
31. Hue L, Maisin L, and Rider MH. Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. Biochem J 251: 541-545, 1988.
32. Ishida T, Lewis RM, Hartley CJ, Entman ML, and Field JB. Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology 112: 1098-1109, 1983.
33. Jahoor F, Peters EJ, and Wolfe RR. The relationship between gluconeogenic substrate supply and glucose production in humans. Am J Physiol Endocrinol Metab 258: E288-E296, 1990.
34. Jenssen T, Nurjhan N, Consoli A, and Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86: 489-497, 1990.
35. Kraus-Friedmann N and Feng L. The role of intracellular Ca2+ in the regulation of gluconeogenesis. Metabolism 45: 389-403, 1996.
36. Kruszynska YT, Mulford MI, Yu JG, Armstrong DA, and Olefsky JM. Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion. Diabetes 46: 1586-1593, 1997.
37. Lam TK, Yoshii H, Haber CA, Bogdanovic E, Lam L, Fantus IG, and Giacca A. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ. Am J Physiol Endocrinol Metab 283: E682-E691, 2002.
38. Lee KU, Park JY, Kim CH, Hong SK, Suh KI, Park KS, and Park SW. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats. Metabolism 45: 1408-1414, 1996.
39. Leevy CM, Mendenhall CL, Lesko W, and Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41: 1169-1179, 1962.
40. Luzi L and DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol Endocrinol Metab 257: E241-E246, 1989.
41. Magnusson I, Rothman DL, Gerard DP, Katz LD, and Shulman GI. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44: 185-189, 1995.
42. McGuinness OP, Burgin K, Moran C, Bracy D, and Cherrington AD. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol Endocrinol Metab 266: E438-E447, 1994.
43. Mithieux G, Bordeto JC, Minassian C, Ajzannay A, Mercier I, and Riou JP. Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid. Lesser inhibitability of the enzyme of diabetic rats. Eur J Biochem 213: 461-466, 1993.
44. Mithieux G and Zitoun C. Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes. Eur J Biochem 235: 799-803, 1996.
45. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, and Gerich J. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39: 1381-1390, 1990.
46. Moore MC, Satake S, Lautz M, Soleimanpour SA, Neal DW, Smith M, and Cherrington AD. Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog. Diabetes 53: 32-40, 2004.
47. Morand C, Besson C, Demigne C, and Remesy C. Importance of the modulation of glycolysis in the control of lactate metabolism by fatty acids in isolated hepatocytes from fed rats. Arch Biochem Biophys 309: 254-260, 1994.
48. Nemecz M, Preininger K, Englisch R, Furnsinn C, Schneider B, Waldhausl W, and Roden M. Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver. Hepatology 29: 166-172, 1999.
49. Pernalete N, Garcia JC, Betts CR, and Martin KJ. Inhibitors of protein kinase-C modulate desensitization of the parathyroid hormone receptor-adenylate cyclase system in opossum kidney cells. Endocrinology 126: 407-413, 1990.
50. Pilkis SJ, Claus TH, and el-Maghrabi MR. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis. Adv Second Messenger Phosphoprotein Res 22: 175-191, 1988.
51. Pilkis SJ and Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54: 885-909, 1992.
52. Puhakainen I and Yki-Jarvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42: 1694-1699, 1993.
53. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
54. Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am 34: 49-62, 2005.
55. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, and Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
56. Rizza R, Haymond M, Cryer P, and Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E356-E362, 1979.
57. Sacca L, Vigorito C, Cicala M, Corso G, and Sherwin RS. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol Endocrinol Metab 245: E294-E302, 1983.
58. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, and Biden TJ. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178, 1997.
59. Shah P, Vella A, Basu A, Basu R, Schwenk WF, and Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85: 4053-4059, 2000.
60. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, and Cherrington AD. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46: 187-196, 1997.
61. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, and Cherrington AD. Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol Endocrinol Metab 260: E363-E370, 1991.
62. Stevenson RW, Steiner KE, Davis MA, Hendrick GK, Williams PE, Lacy WW, Brown L, Donahue P, Lacy DB, and Cherrington AD. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes 36: 382-389, 1987.
63. Summers RJ and McMartin LR. Adrenoceptors and their second messenger systems. J Neurochem 60: 10-23, 1993.
64. Thorburn A, Litchfield A, Fabris S, and Proietto J. Abnormal transient rise in hepatic glucose production after oral glucose in non-insulin-dependent diabetic subjects. Diabetes Res Clin Pract 28: 127-135, 1995.
65. Williamson JR, Kreisberg RA, and Felts PW. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247-254, 1966.
66. Wolfe RR, Jahoor F, and Shaw JH. Effect of alanine infusion on glucose and urea production in man. J Parenter Enteral Nutr 11: 109-111, 1987.